Current Treatment Options in Neurology

Papers
(The TQCC of Current Treatment Options in Neurology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Genetic Testing for Epilepsy: A User Guide54
Education and Team Science in Neurocritical Care49
Updates in the Management of Neuromuscular Emergencies33
Should we Treat Sleep Apnoea to Prevent Dementia?33
Tau in Multiple Sclerosis: A Review of Therapeutic Potential29
Reducing Sudden Unexpected Death in Epilepsy: Considering Risk Factors, Pathophysiology and Strategies24
Continuous EEG in Day to Day Neurocritical Care – A Case Based Review24
Treatment of Symptomatic Carotid Webs: Current Evidence and Future Directions20
Speech Language Pathology in the Neurocritical Care Unit16
Ganaxolone for the Treatment of CDKL5 Disorder and Other Neurological and Psychiatric Conditions: A Review of the Clinical Trials13
Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials13
Correction to: Diagnosis and Management of Progressive Corticobasal Syndrome10
Prourokinase in Acute Ischemic Stroke: A Review of Current Evidence9
Addressing the Burden of Pathological Fatigue in Stroke Survivors: A Review of Present and Potential Non-Pharmacological and Pharmacotherapeutic Options9
Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia9
Treatment of Malignant Cerebral Edema in Acute Ischemic Stroke8
Updates in the Management of Cervical Artery Dissections7
Biomarker Defined Acute Optic Neuritis: A Review and Perspective6
Correction to: Gut Microbiome as Potential Therapeutics in Multiple Sclerosis6
Ocular Myasthenia Gravis6
Epilepsy Management in Transgender and Gender Diverse People5
Updates on Facioscapulohumeral Muscular Dystrophy (FSHD)5
Diagnosis and Treatment of Poststroke Epilepsy: Where Do We Stand?5
Managing the Behavioral and Psychological Symptoms of Dementia5
The A2F ICU Liberation Bundle in Neurocritical Care5
Sleep Neurophysiology and Psychiatric Disorders: a Transdiagnostic Framework for Mechanistic and Therapeutic Insight4
Headache as a Neurologic Manifestation of Systemic Disease4
Management Strategies for Atypical Parkinsonism4
Treatment of Fever in Neurologically Critically Ill Patients4
Update on Stroke Prevention and Treatment in Patients with Antiphospholipid Antibody Syndrome4
Predicting and Treating Post-traumatic Epilepsy4
Mechanical Thrombectomy for Acute Ischemic Stroke: Current State and Future Directions3
Dual Antiplatelet Therapy in Ischemic Stroke Prevention: Which Two Could Be Better than One?3
Key Treatment Issues for Epilepsy in the Context of Autism Spectrum Disorder3
Distinguishing Benign Rashes From Severe Skin Reactions From Anti-Seizure Medications3
The Efficacy of Deep Brain Stimulation in the Treatment of Essential Tremor: A Systematic Review3
Approach to the Management of Sodium Disorders in the Neuro Critical Care Unit3
Update on Treatment of Idiopathic (and Non-Idiopathic) Orbital Inflammation3
Clinical Applications of Non-Invasive Brain Stimulation in Stroke Recovery: A Review of Current Evidence and Therapeutic Strategies3
Diagnosis, Treatment, and Prevention of Stroke in Transgender Adults3
Non-Cognitive Symptoms in Alzheimer’s Disease and Their Likely Impact on Patient Outcomes. A Scoping Review3
Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview3
Treatment Approaches in Pediatric Relapsing Autoimmune Encephalitis3
Correction to: Acute Stroke Treatment in Children: Are Adult Guidelines Applicable?3
Strategic De-escalation of Disease-Modifying Therapies in Elderly Patients: Approaches and Considerations3
Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy3
Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease3
Seizures in the Setting of COVID-193
Telestroke’s Role Through the COVID-19 Pandemic and Beyond3
Current Endovascular Treatments in Neuro-Ophthalmology3
0.051889896392822